labetalol has been researched along with Brain Diseases in 5 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.
Excerpt | Relevance | Reference |
---|---|---|
"Differentiation from acute cerebral ischemia is important in order to prevent permanent vision loss due to delay in initiating prompt and vigorous treatment of exacerbating factors, such as intermittent hypertension." | 1.36 | Postoperative blindness associated with posterior reversible encephalopathy syndrome: a case report. ( Kim, TK; Kim, WS; Lee, HJ; Park, SC; Yoon, JU; Yoon, JY, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, TK | 1 |
Yoon, JU | 1 |
Park, SC | 1 |
Lee, HJ | 1 |
Kim, WS | 1 |
Yoon, JY | 1 |
Morelli, N | 1 |
Gori, S | 1 |
Michelassi, MC | 1 |
Falorni, M | 1 |
Cafforio, G | 1 |
Bianchi, MC | 1 |
Cosottini, M | 1 |
Orlandi, G | 1 |
Murri, L | 1 |
Tartaglione, A | 1 |
Ram, CV | 2 |
Good, CS | 1 |
Meese, RB | 1 |
2 reviews available for labetalol and Brain Diseases
Article | Year |
---|---|
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1984 |
Hypertensive cardiovascular emergencies.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Dia | 1985 |
3 other studies available for labetalol and Brain Diseases
Article | Year |
---|---|
Postoperative blindness associated with posterior reversible encephalopathy syndrome: a case report.
Topics: Adrenergic beta-Antagonists; Adult; Blindness; Brain Diseases; Brain Ischemia; Diagnosis, Differenti | 2010 |
Atypical posterior reversible encephalopathy syndrome in puerperium.
Topics: Adult; Antihypertensive Agents; Brain Diseases; Female; Humans; Hypertensive Encephalopathy; Labetal | 2008 |
Treatment of hypertensive emergencies with oral labetalol.
Topics: Brain Diseases; Emergencies; Ethanolamines; Humans; Hypertension; Labetalol; Male; Middle Aged | 1978 |